Cellular Immune Response in Patients Immunized with Three Vaccine Doses of Different Vaccination Schemes Authorized by the Chilean Ministry of Health in January 2022

In December 2019, a case of atypical pneumonia was reported in Wuhan, China. It was named COVID-19 and caused by SARS-CoV-2. In a few months, scientific groups around the world developed vaccines to reduce the disease’s severity. The objective was to evaluate the humoral and cellular immune response...

Full description

Bibliographic Details

Published in:	Life
Main Authors:	Paz Beatriz Tabilo Valenzuela, Gabriela Flores Balter, Gustavo Saint-Pierre Contreras, Daniel Conei Valencia, Catalina Moreno Calderón, Constanza Bohle Venegas, Marcia Guajardo Rivera, Francisco Silva Ojeda, Maria Jesus Vial Covarrubias
Format:	Article
Language:	English
Published:	MDPI AG 2022-04-01
Subjects:	SARS-CoV-2 COVID-19 vaccines cell-mediated immunity interferon-gamma release assays
Online Access:	https://www.mdpi.com/2075-1729/12/4/534